Kolon Life Science Inc.

KOSDAQ:A102940 Rapporto sulle azioni

Cap. di mercato: ₩227.1b

Kolon Life Science Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Sun Jin Kim

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO1.6yrs
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Risks Still Elevated At These Prices As Kolon Life Science Inc. (KOSDAQ:102940) Shares Dive 26%

Mar 02
Risks Still Elevated At These Prices As Kolon Life Science Inc. (KOSDAQ:102940) Shares Dive 26%

We Think Kolon Life Science (KOSDAQ:102940) Has A Fair Chunk Of Debt

Mar 12
We Think Kolon Life Science (KOSDAQ:102940) Has A Fair Chunk Of Debt

A Look At Kolon Life Science's (KOSDAQ:102940) Share Price Returns

Jan 18
A Look At Kolon Life Science's (KOSDAQ:102940) Share Price Returns

Kolon Life Science (KOSDAQ:102940) Is Carrying A Fair Bit Of Debt

Nov 26
Kolon Life Science (KOSDAQ:102940) Is Carrying A Fair Bit Of Debt

AMMINISTRATORE DELEGATO

Sun Jin Kim (63 yo)

1.6yrs

Mandato

Mr. Sun Jin Kim, M.D, Ph D, is Chief Executive Officer at Kolon Life Science Inc. since April 2023 and serves as its Director. He has been the Chief Medical Officer at Kolon TissueGene, Inc. since June 202...